TODD STRATEGY GROUP

Lobbying for VAXART INC. · Clinical-stage biotechnology company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · $50,000.00 income · posted Oct 12, 2025

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Vaccine policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem